Clinical Trial Update: Tetra PICASSO AD Trial: Study to Evaluate Effects of BPN14770 in Early Alzheimer's Subjects [Phase 2]

View source ↗

Summary

Phase 2 study of BPN14770 in early Alzheimer's disease has completed and results were posted on 2025-02-18.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• BPN14770

Snippet

Sponsor: Tetra Discovery Partners | Conditions: Alzheimer's Disease | Phase 2 | Status: COMPLETED | Results posted: 2025-02-18